The Only Multi-Site QUS Device
Omnisense is the ONLY QUS device that enables measurement at multiple skeletal sites. This advantage provides the physician with higher sensitivity, improved confidence in fracture discrimination, improved monitoring ability, and better measurement flexibility vs. QUS heel systems.

WHO Criteria Compliant
Omnisenses T-score corresponds well with DXA T-scores at the spine and forearm, crossing the -2.5 threshold at the same age point. This demonstrates the applicability of WHO criteria for diagnosis with Omnisense.

Provides Excellent Precision and Sensitivity
Omnisense has the best precision level in the QUS market, between 0.4% - 0.81%, depending on skeletal site.

The heel, the skeletal site measured by most other QUS devices, is not a major fracture site.

User-Friendly Result Output
Omnisense provides a clearly printed, easy-to-read 8.5 by 11 report with T-and Z-score values. Other QUS devices provide a narrow-slip report. On the Omnisense measurement report, current and past results are depicted on the same colored graph for quick detection of a trend in bone strength. Any existing office printer can be hooked up to Omnisense for printout, or results can be viewed on-screen.


An Integrated Male Reference Database
Only Omnisense has a built-in male reference database as part of the system. All other approved QUS devices in the U.S. use female norms to calculate Z-scores for bone measurement in men.

Self-Contained and Transportable
Omnisense is the only QUS device on the market that incorporates a PC in its basic configuration, providing a detailed, high-level, color graphic user interface. Unlike competing products, it does not require connection to an external computer for on-screen viewing of results. The device fits into a suitcase for easy transport.

Numerous Wide-ranging Clinical Studies
Omnisense has been studied in over 200 abstracts and 20 full papers over six years of use in research and four years of clinical use. This is an unprecedented rate of publications relative to sales duration.

Installed Base and Market Leadership Omnisenses worldwide installed base is nearly 2000 units within only four years of sales!
This positions SUNLIGHT as a market leader in QUS sales with an excellent reputation and high brand recognition.
           

                                                                                     Go back to previous page
The Omnipath Advantage
Omnipath,Sunlight Omnisense's unique, patented axial transmission technology, also known as A-QUS (axial quantitative ultrasound) provides comprehensive and accurate bone strength assessment.

A Breakthrough Technology
Omnisense's innovative technology is based on the measurement of the speed of ultrasonic waves propagating along the bone. Omnipath technology enables measurement along the bone's maximal strength axis, eliminating soft tissue effects and providing an accurate diagnosis. Axially transmitted speed of sound (SOS) indicates overall bone strength by reflecting properties such as mineral density, elasticity, cortical thickness and microstructure.

Speed of Sound
Omnisense generates inaudible high-frequency pulsed acoustic waves. Ultrasonic waves are successively transmitted and received by transducers embedded in the hand-held ultrasound probe. By measuring the propagation time along the different trajectories (Time of Flight), the SOS of the bone is determined.

Bone Strength Assessment You Can Rely On
As ultrasound waves pass through bone, the speed, dispersion, and attenuation of the signals are strongly influenced by density, elasticity and cohesiveness. The higher the density of the bone, the greater its modulus of elasticity, and the more cohesive its microstructure, the faster the speed of propagation. Therefore, the faster the speed of propagation, the stronger the bone.

Omnisense is designed to perform measurements along bones such as the distal 1/3 radius, the phalanx, the tibia, and the metatarsal. Results, when used in conjunction with clinical risk factors, aid the physician in the management, diagnosis, and monitoring of osteoporosis.

Multi-Site Advantage
Omnisense's unique probe technology is the only one of its kind. By enabling multi-site measurements, the Omnisense probe system provides you with greater diagnostic ability and enhanced measurement flexibility.

Getting The Whole Picture
Due to the systemic nature of osteoporosis, having a multiple site option provides an overall picture of the skeleton and offers many advantages to the physician:

Combining measurement results of different skeletal sites can optimize fracture risk assessment.

Using multiple measurement sites enables the physician to overcome the dilemma of how to diagnose patients who: